About Red Cedar Ventures

Red Cedar Ventures, a venture investment subsidiary of the Michigan State University Research Foundation, is dedicated to supporting the launch and acceleration of early-stage startups originating from MSU. As the first venture fund in mid-Michigan, Red Cedar Ventures has contributed to the growth of MSU technologies, ecosystem partners, and the state of Michigan. Since 2014, its portfolio has grown to represent some of the most promising high-tech, high-growth startups in the state.

About Michigan Rise

Michigan Rise is a wholly owned venture capital subsidiary of the Michigan State University (MSU) Research Foundation, operated in partnership with the Michigan Economic Development Corporation (MEDC). Michigan Rise provides early-stage funding to innovative companies that have the potential to transform industries and create jobs in Michigan.

About Apjohn Group

Apjohn Group, LLC, is an accomplished team of experienced business and pharmaceutical professionals that has demonstrated success in working with innovators to accelerate the advancement of early-stage life science companies. Our focus is on emerging life science opportunities, which complement our unique strengths in biopharmaceuticals, devices, diagnostics and medical technologies.

About Biosciences Research and Commercialization Center (BRCC)

Established in 2003 by the Michigan Legislature, the Biosciences Research and Commercialization Center (BRCC) is located at Western Michigan University and is perfectly positioned to access the wealth of scientific talent and pharmaceutical commercialization expertise that is part of Kalamazoo’s heritage. Long-time home to such industry giants as the Upjohn Co., Richard-Allan Scientific, Stryker Corp. and Pfizer Inc., Kalamazoo offers a forward-looking, entrepreneurial business climate and a growing reputation among venture capitalists seeking to invest in life sciences discoveries and promising business ventures. The BRCC provides startup and gap funding to promising Michigan-based life sciences and medical device ventures entering the commercialization phase of development.